Conference Overview

April 8-10, 2022

Great Debates in Cardiometabolic Medicine:

CMHC Spring 2022

The Westin Kierland Resort & Spa
6902 East Greenway Parkway
Scottsdale, AZ 85254


World-renowned experts will present on the latest developments in cardiovascular disease, chronic kidney disease, obesity & lifestyle, type 2 diabetes, lipids, and more.

The meeting will include extensive expert panel discussions and debates, as well as ample opportunities for audience Q & A, with the goal of enhancing the interactions with thought leaders and to help clinicians walk away with practical advice to apply directly to patient care.

What to Expect

Highlighting the most current, relevant, and applicable education in the field, this conference allows attendees to learn specific strategies to combat the growing epidemic of cardiometabolic risk and disease.

Access the Latest Clinical Education

Through three days of comprehensive clinical education in cardiometabolic health, attendees will have the opportunity to learn the latest data and expert perspectives to improve patient care across several disease areas, including obesity, lifestyle medicine, diabetes, cardiovascular disease, and cardiorenal risk.

Hear From World-Renowned Faculty, Clinicians, & Speakers

Each lecture & session at CMHC is carefully curated and planned by our faculty, including a panel of Chairpersons that represent the most respected & renowned leaders in the field.

Network & Socializing Opportunities with Peers

Develop new connections with like-minded peers through numerous networking opportunities designed to foster engaging social environments.

Interactive Learning with World Renowned Faculty Members

Engage directly with a multitude of leaders who are shaping the field of cardiometabolic medicine.

Conference Chairs & SPC

Conference Faculty

Conference Agenda

7:00 AM – 8:30 AM
CME Breakfast Symposium
Bridging the Frontiers of Care in Patients with Type 2 Diabetes and Chronic Kidney Disease: Interpreting the Data with Novel MR Antagonists to Improve Cardiorenal Outcomes

George L. Bakris, MD (Chair); Rajiv Agarwal, MD; Katherine R. Tuttle, MD
Supported by an educational grant from Bayer HealthCare Pharmaceuticals Inc.
8:30 AM
Chair Introduction
George L. Bakris, MD
8:30 AM – 9:15 AM
Outcomes Trials in Chronic Kidney Disease
Rajiv Agarwal, MD; Katherine R. Tuttle, MD
I. Improving Renal Outcomes with SGLT-2 Inhibitors and GLP-1 RAs: Data, Interpretations, and Future Outlook
II. CKD Challenging Case & Expert Panel Discussion
9:15 AM – 9:30 AM
Mini Break
9:30 AM – 11:00 AM
Outcomes Trials in Heart Failure
I. SGLT-2is and ARNI Across the HF Spectrum – Alanna A. Morris MD
II. New and Emerging Treatment Targets in Heart Failure – Ileana L Piña, MD
III. ATTR-CM in African Americans: Advances in Diagnosis and Treatment to Help Reduce Disparities and Improve Outcomes
This session is supported in part by an educational grant from Alnylam Pharmaceuticals, Inc.
Keith C. Ferdinand, MD

IV. HF Challenging Cases & Expert Panel Discussion
11:00 AM – 11:45 AM
Emerging Developments in Hypertension
I. Emerging Treatments for Hypertension – Keith C. Ferdinand, MD
II. Resistant Hypertension: Old and New – Debbie Cohen, MD
III. Expert Panel Discussion & Audience Q & A
11:45 AM – 12:15 PM
Morning Break & Exhibits
12:15 PM – 1:15 PM
PME Lunch Symposium
A Treatment Option for Patients With HFrEF Following a Worsening HF Event

Matthew J. Budoff, MD
Sponsored by Merck Sharp and Dohme Corp.
1:15 PM – 1:45 PM
Break & Exhibits
1:45 PM – 2:30 PM
Cardiometabolic Centers of Excellence – a novel care delivery model to improve quality and outcomes in cardiometabolic disease
Mikhail N. Kosiborod, MD
2:30 PM
Chair Introduction
Anne L. Peters, MD
2:30 PM – 2:50 PM
Prediabetes: Screening, Diagnosis, and Management
Leigh Perreault, MD
2:50 PM – 3:25 PM
Continuous Glucose Monitoring: Going Beyond HbA1c to Optimize and Individualize the Management of Type 2 Diabetes
This session is supported by Abbott Diabetes.
Viral Shah, MD
3:25 PM – 3:45 PM
Dual GLP-1/GIP Agonists: Are They the Next Big Thing in Diabetes Treatment?
Athena Philis-Tsimikas, MD
3:45 PM – 4:00 PM
Afternoon Break & Exhibits
4:00 PM – 4:20 PM
How Can We Converge the Glucocentric and Cardio-Renal Risk Management in Diabetes Patients?
Lawrence A. Leiter MD
4:20 PM – 4:40 PM
The Evolution of Insulin: A 2022 Update
Grazia Aleppo, MD, FACE, FACP
4:40 PM – 5:00 PM
Technology in Diabetes Beyond CGM
Steven J. Russell MD, PhD
5:00 PM – 5:30 PM
Expert Panel Discussion & Audience Q & A
Moderator: Anne L. Peters, MD
Panelists: Viral Shah, MD ; Athena Philis-Tsimikas, MD; Lawrence A. Leiter MD; Grazia Aleppo, MD, FACE, FACP; Steven J. Russell MD, PhD
5:30 PM
Closing Remarks
Anne L. Peters, MD
5:30 PM – 6:30 PM
Opening Reception
7:30 AM – 8:30 AM
CME Breakfast Symposium
The Evolving Landscape of LDL-C Reduction in High-Risk Patients: Optimizing Combination Therapy to Reduce ASCVD Risk

Christie M. Ballantyne, MD (Chair); Nihar R. Desai, MD; Erin D. Michos, MD; Robert S. Rosenson, MD
Supported by an educational grant from Novartis Pharmaceuticals Corporation.
8:30 AM – 8:35 AM
Chair Introduction and Opening Remarks
Robert H. Eckel, MD
8:35 AM – 9:35 AM
Lifestyle Approaches to Target Obesity & Cardiometabolic Risk
I. Physical Activity – John Jakicic, PhD
II. Nutrition and Cardiometabolic Risk – Maya Vadiveloo, PhD, RD
III. Motivational Interviewing and Behavioral Strategies to Address Weight Management – Holly R. Wyatt, MD
9:35 AM – 9:55 AM
The Evolving Landscape of NAFLD and NASH
Kenneth Cusi, MD
9:55 AM – 10:35 AM
To Be Resolved: Which Approach is Better for Weight Loss?
I. Medical Management – Holly R. Wyatt, MD
II. Metabolic Surgery – Donna H. Ryan, MD
III. Clinical Implications: Expert Discussions & Audience Q/A
10:35 AM – 11:05 AM
Morning Break & Exhibits
11:05 AM – 11:25 AM
Addressing Bias, Stigma & Racial Disparities in Obesity Care
Fatima C. Stanford, MD
11:25 AM – 12:05 PM
Challenging Cases & Expert Panel Discussion
Moderator: Robert H. Eckel, MD
Panelists: John Jakicic, PhD; Maya Vadiveloo, PhD, RD; Holly R. Wyatt, MD; Fatima C. Stanford, MD; Donna H. Ryan, MD
12:05 PM – 12:10 PM
Closing Remarks
Robert H. Eckel, MD
12:10 PM – 12:25 PM
12:25 PM – 1:25 PM
CME Lunch Symposium
Changing The Treatment Paradigm for LDL-C Lowering Post-MI: The Case for Early, ‘High-Intensity Lipid Lowering Therapy’ to Improve Outcomes

Christie M. Ballantyne, MD (Chair); Salim S. Virani, MD, Pam R. Taub, MD
This activity is supported by educational funding provided by Amgen.
1:25 PM – 1:40 PM
1:40 PM – 1:45 PM
Chair Introduction
Christie M. Ballantyne, MD
1:45 PM – 2:05 PM
ASCVD Risk Assessment and Prevention: Where Do We Stand Now?
Salim S. Virani, MD
2:05 PM – 2:25 PM
LDL-C-Lowering Therapies: New Approaches to Address Old Challenges
Pam R. Taub, MD
2:25 PM – 2:45 PM
Lp(a) and Cardiovascular Risk
Michael Wilkinson, MD
2:45 PM – 3:15 PM
Afternoon Break & Exhibits
3:15 PM – 3:35 PM
What’s the Scoop with Triglycerides and ASCVD Risk?
Karol E. Watson, MD
3:35 PM – 3:55 PM
The Spectrum of Familial Hypercholesterolemia
Robert S. Rosenson, MD
3:55 PM – 4:15 PM
Updates in Antithrombotic Therapy for the Cardiometabolic Patient
Roxana Mehran, MD
4:15 PM – 5:00 PM
Challenging Cases & Expert Panel Discussion and Q&A
Moderator: Christie M. Ballantyne, MD
Panelists: Robert H. Eckel, MD; Salim S. Virani, MD; Pam R. Taub, MD; Michael Wilkinson, MD; Karol E. Watson, MD; Robert S. Rosenson, MD; Roxana Mehran, MD
5:00 PM
Closing Remarks
Christie M. Ballantyne, MD
5:00 PM – 6:00 PM
Happy Hour & Giveaways
7:30 AM – 8:00 AM
8:00 AM – 8:05 AM
Introduction and Opening Remarks
Christie M. Ballantyne, MD
8:05 AM – 9:05 AM
Do patients benefit from Omega-3 Fatty Acids for CVD Prevention?
Christie M. Ballantyne, MD; Michael Miller, MD; Karol E. Watson, MD
I. Yes
II. No
III. Expert Discussions & Audience Q/A
9:05 AM – 10:05 AM
What is the Standard of Care for Heart Failure with Preserved Ejection Fraction (HFpEF)?
Ileana L Piña, MD; Mikhail N. Kosiborod, MD; Alanna A. Morris, MD
I. SGLT-2 Inhibitors
II. ARNI and Others
III. Expert Discussions & Audience Q/A
10:05 AM – 10:20 AM
10:20 AM – 11:20 AM
Drawing The Line Between Primary and Secondary Cardiovascular Prevention: Essential or Too Simplistic?.
Christie Ballantyne, MD; Pam R. Taub, MD; Salim S. Virani, MD
I. Essential
II. Too Simplistic
III. Expert Discussions & Audience Q/A
11:20 AM – 12:20 PM
The Plate Debate: Which Approach is Better for the Management of Obesity and Cardiometabolic Risk?
Robert H. Eckel, MD; Monica Aggarwal, MD; David Ludwig, MD; Holly R. Wyatt, MD
I. Plant-based diets
II. Low-carb diets
III. It’s more complex than that
IV. Expert Discussions & Audience Q/A
12:20 PM – 12:30 PM
Closing Remarks
Christie M. Ballantyne, MD

Event Registration

We are pleased to announce that all CME sessions from this conference will be available for complimentary on-demand viewing and CE credit until 4/10/23. This virtual add-on is included with your event registration and allows our in-person audience to experience session highlights from home for up to one year after the meeting concludes.

Allied Health Professionals
Fellows / Residents / Students*
Slide table to see all pricing options

*Must submit proof of residency, fellowship or student ID

Conference Venue

Join us at The Westin Kierland Resort & Spa

Attendees will receive the conference group rate of $295 + tax per room, per night. The group rate is guaranteed for reservations made on or before March 16, 2022, or until the CMHC room block is filled. When booking, mention group code CMHC

Conference Venue

The Westin Kierland Resort & Spa

6902 East Greenway Parkway
Scottsdale, AZ 85254

Room Rate: $295/night plus tax
Rate expires: 3-16-2022
Room Reservation Phone: (480) 624-1000

CMHC Sponsors & Partners

Join this year’s illustrious lineup of brand partners and take your 2022 goals to the next level.


Sign up to receive updates on educational opportunities, complimentary content, exclusive discounts, and more.